Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:54:07 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



News for C:RX from 2023-05-08 to 2024-05-07 - 33 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-25 10:13C:RXBioSyent Inc8.40SEDAR Annual ReportSEDAR Annual Report
2024-04-15 16:50C:RXBioSyent Inc8.64News ReleaseBioSyent extends licence for RepaGyn, Proktis-M
2024-03-27 18:38C:RXBioSyent Inc8.70News ReleaseBioSyent grants 66,020 RSUs
2024-03-13 17:47C:RXBioSyent Inc8.65SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-13 17:47C:RXBioSyent Inc8.65SEDAR MD & ASEDAR MD & A
2024-03-13 17:41C:RXBioSyent Inc8.65News ReleaseBioSyent earns $6.46-million in 2023
2024-03-06 16:37C:RXBioSyent Inc8.65News ReleaseBioSyent to release fiscal 2023 results March 13
2024-02-06 16:35C:RXBioSyent Inc8.75News ReleaseBioSyent increases quarterly dividend to 4.5 cents
2024-02-06 16:11C:RXBioSyent Inc8.60Dividend DeclaredBioSyent to pay 4.5-cent dividend
2023-12-13 16:12C:RXBioSyent Inc8.62Normal Course Issuer BidBioSyent normal course issuer bid
2023-12-13 11:47C:RXBioSyent Inc8.62News ReleaseBioSyent may buy back up to 650,000 shares under NCIB
2023-11-20 11:02C:RXBioSyent Inc8.30News ReleaseBioSyent begins shipping Gelclair to Canada
2023-11-16 10:23C:RXBioSyent Inc8.00News ReleaseBioSyent earns $2.35-million in Q3 2023
2023-11-16 08:13C:RXBioSyent Inc8.00SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-16 08:12C:RXBioSyent Inc8.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-15 16:39C:RXBioSyent Inc8.00News ReleaseBioSyent to pay four-cent dividend Dec. 15
2023-11-09 13:57C:RXBioSyent Inc8.00News ReleaseBioSyent to release Q3 results Nov. 16
2023-10-18 11:42C:RXBioSyent Inc8.00News ReleaseBioSyent rolls out menopauseinformation website
2023-08-22 16:44C:RXBioSyent Inc7.60SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-22 16:41C:RXBioSyent Inc7.60SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-22 16:30C:RXBioSyent Inc7.60News ReleaseBioSyent earns $1.48-million in Q2 2023
2023-08-22 16:13C:RXBioSyent Inc7.60News ReleaseBioSyent to pay four-cent dividend Sept. 15
2023-08-15 16:33C:RXBioSyent Inc7.60News ReleaseBioSyent to release Q2 2023 results Aug. 22
2023-08-08 12:04C:RXBioSyent Inc7.55News ReleaseBioSyent begins shipping Inofolic to Canada
2023-07-06 18:02C:RXBioSyent Inc7.03News ReleaseBioSyent to introduce Gelclair product at AHNS
2023-06-20 11:48C:RXBioSyent Inc7.20News ReleaseBioSyent unit extends Cathejell licence deal
2023-05-31 17:50C:RXBioSyent Inc7.30News ReleaseBioSyent Pharma receives Health Canada OK for product
2023-05-26 09:20C:RXBioSyent Inc7.87News ReleaseBioSyent earns $1.17-million in Q1 2023
2023-05-26 08:09C:RXBioSyent Inc7.87SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-26 08:09C:RXBioSyent Inc7.87SEDAR MD & ASEDAR MD & A
2023-05-25 18:06C:RXBioSyent Inc7.87News ReleaseBioSyent to pay four-cent quarterly dividend June 15
2023-05-25 16:06C:RXBioSyent Inc7.73Dividend DeclaredBioSyent four-cent dividend
2023-05-18 12:39C:RXBioSyent Inc7.60News ReleaseBioSyent to release Q1 2023 results May 26